Abstract
Secondary thrombotic microangiopathy (TMA) can present in the setting of drug intake, pregnancy, snake bite, malignant hypertension, pancreatitis and underlying autoimmune disease. Several of these patients have underlying genetic defect in complement pathway. The risk of progression to ESRD (End Stage Renal Disease) in TMA is high and it is known to recur post-transplant.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
